{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2 Mpro", "in silico screening", "molecular docking calculations", "molecular dynamics (MD) simulations", "reactome", "toxins"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35215266", "DateRevised": {"Year": "2022", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "27"}], "Language": ["eng"], "ELocationID": ["153", "10.3390/ph15020153"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "15", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "27"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study.", "Abstract": {"AbstractText": ["The main protease (M<sup>pro</sup>) is a potential druggable target in SARS-CoV-2 replication. Herein, an in silico study was conducted to mine for M<sup>pro</sup> inhibitors from toxin sources. A toxin and toxin-target database (T3DB) was virtually screened for inhibitor activity towards the M<sup>pro</sup> enzyme utilizing molecular docking calculations. Promising toxins were subsequently characterized using a combination of molecular dynamics (MD) simulations and molecular mechanics-generalized Born surface area (MM-GBSA) binding energy estimations. According to the MM-GBSA binding energies over 200 ns MD simulations, three toxins-namely philanthotoxin (T3D2489), azaspiracid (T3D2672), and taziprinone (T3D2378)-demonstrated higher binding affinities against SARS-CoV-2 M<sup>pro</sup> than the co-crystalized inhibitor XF7 with MM-GBSA binding energies of -58.9, -55.9, -50.1, and -43.7 kcal/mol, respectively. The molecular network analyses showed that philanthotoxin provides a ligand lead using the STRING database, which includes the biochemical top 20 signaling genes CTSB, CTSL, and CTSK. Ultimately, pathway enrichment analysis (PEA) and Reactome mining results revealed that philanthotoxin could prevent severe lung injury in COVID-19 patients through the remodeling of interleukins (IL-4 and IL-13) and the matrix metalloproteinases (MMPs). These findings have identified that philanthotoxin-a venom of the Egyptian solitary wasp-holds promise as a potential M<sup>pro</sup> inhibitor and warrants further in vitro/in vivo validation."]}, "AuthorList": [{"Identifier": ["0000-0003-4819-2040"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Ibrahim", "ForeName": "Mahmoud A A", "Initials": "MAA"}, {"Identifier": ["0000-0003-3527-0126"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Abdelrahman", "ForeName": "Alaa H M", "Initials": "AHM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Kuwait University, Kuwait City 13060, Kuwait."}, {"Identifier": [], "Affiliation": "Cardiovascular and Metabolic Sciences Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA."}], "LastName": "Jaragh-Alhadad", "ForeName": "Laila A", "Initials": "LA"}, {"Identifier": ["0000-0003-2462-1269"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Genetics and Genome Mapping Laboratory, Genome Mapping Department, Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center (ARC), Giza 12619, Egypt."}], "LastName": "Atia", "ForeName": "Mohamed A M", "Initials": "MAM"}, {"Identifier": ["0000-0002-2726-0473"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia."}], "LastName": "Alzahrani", "ForeName": "Othman R", "Initials": "OR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, The University of Azad Jammu and Kashmir, Muzaffarabad 13100, Pakistan."}], "LastName": "Ahmed", "ForeName": "Muhammad Naeem", "Initials": "MN"}, {"Identifier": ["0000-0002-3694-5845"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Kuwait University, Kuwait City 13060, Kuwait."}], "LastName": "Moustafa", "ForeName": "Moustafa Sherief", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa."}], "LastName": "Soliman", "ForeName": "Mahmoud E S", "Initials": "MES"}, {"Identifier": ["0000-0002-3035-661X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Unit (STU), Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Shawky", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0003-1644-723X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, TX 79409, USA."}], "LastName": "Par\u00e9", "ForeName": "Paul W", "Initials": "PW"}, {"Identifier": ["0000-0002-0343-4969"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt."}], "LastName": "Sidhom", "ForeName": "Peter A", "Initials": "PA"}], "GrantList": [{"GrantID": "5480", "Agency": "Science and Technology Development Fund", "Country": ""}, {"GrantID": "7972", "Agency": "Science and Technology Development Fund", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u2013269. doi: 10.1038/s41586-020-2008-3.", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536\u2013544.", "ArticleIdList": ["PMC7095448", "32123347"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "WHO Coronavirus Disease (COVID-19) Dashboard.  [(accessed on 29 December 2021)].  Available online:  https://covid19.who.int/"}, {"Citation": "WHO COVID-19 Vaccines.  [(accessed on 29 December 2021)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines."}, {"Citation": "Li Q., Kang C. Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease. Microorganisms. 2020;8:1250. doi: 10.3390/microorganisms8081250.", "ArticleIdList": ["10.3390/microorganisms8081250", "PMC7463875", "32824639"]}, {"Citation": "Suarez D., Diaz N. SARS-CoV-2 Main Protease: A Molecular Dynamics Study. J. Chem. Inf. Model. 2020;60:5815\u20135831. doi: 10.1021/acs.jcim.0c00575.", "ArticleIdList": ["10.1021/acs.jcim.0c00575", "32678588"]}, {"Citation": "Verma S., Twilley D., Esmear T., Oosthuizen C.B., Reid A.M., Nel M., Lall N. Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19) Front. Pharmacol. 2020;11:561334. doi: 10.3389/fphar.2020.561334.", "ArticleIdList": ["10.3389/fphar.2020.561334", "PMC7546787", "33101023"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Allemailem K.S., Almatroudi A., Moustafa M.F., Hegazy M.F. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. Protein J. 2021;40:296\u2013309. doi: 10.1007/s10930-020-09945-6.", "ArticleIdList": ["10.1007/s10930-020-09945-6", "PMC7776322", "33387249"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hegazy M.F. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J. Biomol. Struct. Dyn. 2021;39:5756\u20135767. doi: 10.1080/07391102.2020.1791958.", "ArticleIdList": ["10.1080/07391102.2020.1791958", "PMC7441803", "32684114"]}, {"Citation": "Caly L., Druce J.D., Catton M.G., Jans D.A., Wagstaff K.M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir. Res. 2020;178:104787. doi: 10.1016/j.antiviral.2020.104787.", "ArticleIdList": ["10.1016/j.antiviral.2020.104787", "PMC7129059", "32251768"]}, {"Citation": "Liu J., Cao R.Y., Xu M.Y., Wang X., Zhang H.Y., Hu H.R., Li Y.F., Hu Z.H., Zhong W., Wang M.L. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16. doi: 10.1038/s41421-020-0156-0.", "ArticleIdList": ["10.1038/s41421-020-0156-0", "PMC7078228", "32194981"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hussien T.A., Badr E.A.A., Mohamed T.A., El-Seedi H.R., Pare P.W., Efferth T., Hegazy M.F. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput. Biol. Med. 2020;126:104046. doi: 10.1016/j.compbiomed.2020.104046.", "ArticleIdList": ["10.1016/j.compbiomed.2020.104046", "PMC7543985", "33065388"]}, {"Citation": "Ibrahim M.A.A., Mohamed E.A.R., Abdelrahman A.H.M., Allemailem K.S., Moustafa M.F., Shawky A.M., Mahzari A., Hakami A.R., Abdeljawaad K.A.A., Atia M.A.M. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. J. Mol. Graph. Model. 2021;105:107904. doi: 10.1016/j.jmgm.2021.107904.", "ArticleIdList": ["10.1016/j.jmgm.2021.107904", "PMC7980232", "33798836"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Atia M.A.M., Mohamed T.A., Moustafa M.F., Hakami A.R., Khalifa S.A.M., Alhumaydhi F.A., Alrumaihi F., Abidi S.H., et al. Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition. Mar Drugs. 2021;19:391. doi: 10.3390/md19070391.", "ArticleIdList": ["10.3390/md19070391", "PMC8308023", "34356816"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Mohamed T.A., Atia M.A.M., Al-Hammady M.A.M., Abdeljawaad K.A.A., Elkady E.M., Moustafa M.F., Alrumaihi F., Allemailem K.S., et al. In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M(pro)) Inhibitors. Molecules. 2021;26:2082. doi: 10.3390/molecules26072082.", "ArticleIdList": ["10.3390/molecules26072082", "PMC8038614", "33916461"]}, {"Citation": "Ibrahim M.A.A., Abdeljawaad K.A.A., Abdelrahman A.H.M., Hegazy M.F. Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: In-silico drug discovery. J. Biomol. Struct. Dyn. 2021;39:5722\u20135734. doi: 10.1080/07391102.2020.1790037.", "ArticleIdList": ["10.1080/07391102.2020.1790037", "PMC7443551", "32643529"]}, {"Citation": "Zakaryan H., Arabyan E., Oo A., Zandi K. Flavonoids: Promising natural compounds against viral infections. Arch. Virol. 2017;162:2539\u20132551. doi: 10.1007/s00705-017-3417-y.", "ArticleIdList": ["10.1007/s00705-017-3417-y", "PMC7087220", "28547385"]}, {"Citation": "Cherrak S.A., Merzouk H., Mokhtari-Soulimane N. Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies. PLoS ONE. 2020;15:e0240653\u2013e0240666. doi: 10.1371/journal.pone.0240653.", "ArticleIdList": ["10.1371/journal.pone.0240653", "PMC7561147", "33057452"]}, {"Citation": "Jo S., Kim S., Kim D.Y., Kim M.-S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J. Enzym. Inhib. Med. Chem. 2020;35:1539\u20131544. doi: 10.1080/14756366.2020.1801672.", "ArticleIdList": ["10.1080/14756366.2020.1801672", "PMC7470085", "32746637"]}, {"Citation": "Fact Sheet for Healthcare Providers: Emergency Use Authorization for PAXLOVID.  [(accessed on 20 December 2021)]; Available online:  https://www.fda.gov/media/155050/download."}, {"Citation": "Harvey A.L. Toxins and drug discovery. Toxicon. 2014;92:193\u2013200. doi: 10.1016/j.toxicon.2014.10.020.", "ArticleIdList": ["10.1016/j.toxicon.2014.10.020", "25448391"]}, {"Citation": "Bordon K.C.F., Cologna C.T., Fornari-Baldo E.C., Pinheiro-Junior E.L., Cerni F.A., Amorim F.G., Anjolette F.A.P., Cordeiro F.A., Wiezel G.A., Cardoso I.A., et al. From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery. Front. Pharmacol. 2020;11:1132\u20131160. doi: 10.3389/fphar.2020.01132.", "ArticleIdList": ["10.3389/fphar.2020.01132", "PMC7396678", "32848750"]}, {"Citation": "Lim E., Pon A., Djoumbou Y., Knox C., Shrivastava S., Guo A.C., Neveu V., Wishart D.S. T3DB: A comprehensively annotated database of common toxins and their targets. Nucleic Acids Res. 2010;38:D781\u2013D786. doi: 10.1093/nar/gkp934.", "ArticleIdList": ["10.1093/nar/gkp934", "PMC2808899", "19897546"]}, {"Citation": "Mohamed T.A., Elshamy A.I., Ibrahim M.A.A., Atia M.A.M., Ahmed R.F., Ali S.K., Mahdy K.A., Alshammari S.O., Al-Abd A.M., Moustafa M.F., et al. Gastroprotection against Rat Ulcers by Nephthea Sterol Derivative. Biomolecules. 2021;11:1247. doi: 10.3390/biom11081247.", "ArticleIdList": ["10.3390/biom11081247", "PMC8393318", "34439913"]}, {"Citation": "Zhang C.H., Stone E.A., Deshmukh M., Ippolito J.A., Ghahremanpour M.M., Tirado-Rives J., Spasov K.A., Zhang S., Takeo Y., Kudalkar S.N., et al. Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations. ACS Cent. Sci. 2021;7:467\u2013475. doi: 10.1021/acscentsci.1c00039.", "ArticleIdList": ["10.1021/acscentsci.1c00039", "PMC7931627", "33786375"]}, {"Citation": "Wellendorph P., Jaroszewski J.W., Hansen S.H., Franzyk H. A sequential high-yielding large-scale solution-method for synthesis of philanthotoxin analogues. Eur. J. Med. Chem. 2003;38:117\u2013122. doi: 10.1016/S0223-5234(02)00003-X.", "ArticleIdList": ["10.1016/S0223-5234(02)00003-X", "12593922"]}, {"Citation": "Satake M., Ofuji K., Naoki H., James K.J., Furey A., McMahon T., Silke J., Yasumoto T. Azaspiracid, a new marine toxin having unique spiro ring assemblies, isolated from Irish mussels, Mytilus edulis. J. Am. Chem. Soc. 1998;120:9967\u20139968. doi: 10.1021/ja981413r.", "ArticleIdList": ["10.1021/ja981413r"]}, {"Citation": "De Vivo M., Masetti M., Bottegoni G., Cavalli A. Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 2016;59:4035\u20134061. doi: 10.1021/acs.jmedchem.5b01684.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01684", "26807648"]}, {"Citation": "Shen M., Tian S., Li Y., Li Q., Xu X., Wang J., Hou T. Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J. Cheminform. 2012;4:31. doi: 10.1186/1758-2946-4-31.", "ArticleIdList": ["10.1186/1758-2946-4-31", "PMC3538521", "23181938"]}, {"Citation": "Han Y., Zhang J., Hu C.Q., Zhang X., Ma B., Zhang P. In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities. Front. Pharmacol. 2019;10:434. doi: 10.3389/fphar.2019.00434.", "ArticleIdList": ["10.3389/fphar.2019.00434", "PMC6491819", "31068821"]}, {"Citation": "Bakht M.A., Yar M.S., Abdel-Hamid S.G., Al Qasoumi S.I., Samad A. Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives. Eur. J. Med. Chem. 2010;45:5862\u20135869. doi: 10.1016/j.ejmech.2010.07.069.", "ArticleIdList": ["10.1016/j.ejmech.2010.07.069", "20965619"]}, {"Citation": "Pires D.E., Blundell T.L., Ascher D.B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Dahlgren D., Lennernas H. Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches. Pharmaceutics. 2019;11:411. doi: 10.3390/pharmaceutics11080411.", "ArticleIdList": ["10.3390/pharmaceutics11080411", "PMC6723276", "31412551"]}, {"Citation": "Zanger U.M., Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 2013;138:103\u2013141. doi: 10.1016/j.pharmthera.2012.12.007.", "ArticleIdList": ["10.1016/j.pharmthera.2012.12.007", "23333322"]}, {"Citation": "Zhou Y., Vedantham P., Lu K., Agudelo J., Carrion R., Jr., Nunneley J.W., Barnard D., Pohlmann S., McKerrow J.H., Renslo A.R., et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral. Res. 2015;116:76\u201384. doi: 10.1016/j.antiviral.2015.01.011.", "ArticleIdList": ["10.1016/j.antiviral.2015.01.011", "PMC4774534", "25666761"]}, {"Citation": "Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11:1620. doi: 10.1038/s41467-020-15562-9.", "ArticleIdList": ["10.1038/s41467-020-15562-9", "PMC7100515", "32221306"]}, {"Citation": "Zhao M.M., Yang W.L., Yang F.Y., Zhang L., Huang W.J., Hou W., Fan C.F., Jin R.H., Feng Y.M., Wang Y.C., et al. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct. Target. Ther. 2021;6:134. doi: 10.1038/s41392-021-00558-8.", "ArticleIdList": ["10.1038/s41392-021-00558-8", "PMC7997800", "33774649"]}, {"Citation": "Liu T., Luo S., Libby P., Shi G.P. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacol. Ther. 2020;213:107587. doi: 10.1016/j.pharmthera.2020.107587.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107587", "PMC7255230", "32470470"]}, {"Citation": "Smieszek S.P., Przychodzen B.P., Polymeropoulos M.H. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment. Int. J. Antimicrob. Agents. 2020;55:106004. doi: 10.1016/j.ijantimicag.2020.106004.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.106004", "PMC7191300", "32361028"]}, {"Citation": "Gomes C.P., Fernandes D.E., Casimiro F., da Mata G.F., Passos M.T., Varela P., Mastroianni-Kirsztajn G., Pesquero J.B. Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics. Front. Cell. Infect. Microbiol. 2020;10:589505. doi: 10.3389/fcimb.2020.589505.", "ArticleIdList": ["10.3389/fcimb.2020.589505", "PMC7753008", "33364201"]}, {"Citation": "Vaz de Paula C.B., de Azevedo M.L.V., Nagashima S., Martins A.P.C., Malaquias M.A.S., Miggiolaro A., da Silva Motta Junior J., Avelino G., do Carmo L.A.P., Carstens L.B., et al. IL-4/IL-13 remodeling pathway of COVID-19 lung injury. Sci. Rep. 2020;10:18689. doi: 10.1038/s41598-020-75659-5.", "ArticleIdList": ["10.1038/s41598-020-75659-5", "PMC7596721", "33122784"]}, {"Citation": "Guizani I., Fourti N., Zidi W., Feki M., Allal-Elasmi M. SARS-CoV-2 and pathological matrix remodeling mediators. Inflamm. Res. 2021;70:847\u2013858. doi: 10.1007/s00011-021-01487-6.", "ArticleIdList": ["10.1007/s00011-021-01487-6", "PMC8294315", "34286362"]}, {"Citation": "Gordon J.C., Myers J.B., Folta T., Shoja V., Heath L.S., Onufriev A. H++: A server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33:W368\u2013W371. doi: 10.1093/nar/gki464.", "ArticleIdList": ["10.1093/nar/gki464", "PMC1160225", "15980491"]}, {"Citation": "OMEGA, 2.5.1.4. OpenEye Scientific Software; Santa Fe, NM, USA: 2013."}, {"Citation": "Hawkins P.C., Skillman A.G., Warren G.L., Ellingson B.A., Stahl M.T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J. Chem. Inf. Model. 2010;50:572\u2013584. doi: 10.1021/ci100031x.", "ArticleIdList": ["10.1021/ci100031x", "PMC2859685", "20235588"]}, {"Citation": "SZYBKI 1.9.0.3, 1.9.0.3. OpenEye Scientific Software; Santa Fe, NM, USA: 2016."}, {"Citation": "Halgren T.A. MMFF VI. MMFF94s option for energy minimization studies. J. Comput. Chem. 1999;20:720\u2013729. doi: 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X", "34376030"]}, {"Citation": "QUACPAC, 1.7.0.2. OpenEye Scientific Software; Santa Fe, NM, USA: 2016."}, {"Citation": "Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity\u2014A rapid access to atomic charges. Tetrahedron. 1980;36:3219\u20133228. doi: 10.1016/0040-4020(80)80168-2.", "ArticleIdList": ["10.1016/0040-4020(80)80168-2"]}, {"Citation": "Heller S.R., McNaught A., Pletnev I., Stein S., Tchekhovskoi D. InChI, the IUPAC International Chemical Identifier. J. Cheminform. 2015;7:23. doi: 10.1186/s13321-015-0068-4.", "ArticleIdList": ["10.1186/s13321-015-0068-4", "PMC4486400", "26136848"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905\u2013919. doi: 10.1038/nprot.2016.051.", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Mansourian M., Fassihi A., Saghaie L., Madadkar-Sobhani A., Mahnam K., Abbasi M. QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold. Med. Chem. Res. 2014;24:394\u2013407. doi: 10.1007/s00044-014-1133-7.", "ArticleIdList": ["10.1007/s00044-014-1133-7"]}, {"Citation": "Case D.A., Betz R.M., Cerutti D.S., Cheatham T.E., Darden T.A., Duke R.E., Giese T.J., Gohlke H., Goetz A.W., Homeyer N., et al. AMBER 2016. University of California; San Francisco, CA, USA: 2016."}, {"Citation": "Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157\u20131174. doi: 10.1002/jcc.20035.", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696\u20133713. doi: 10.1021/acs.jctc.5b00255.", "ArticleIdList": ["10.1021/acs.jctc.5b00255", "PMC4821407", "26574453"]}, {"Citation": "Bayly C.I., Cieplak P., Cornell W.D., Kollman P.A. A Well-Behaved Electrostatic Potential Based Method Using Charge Restraints for Deriving Atomic Charges\u2014The Resp Model. J. Phys. Chem. 1993;97:10269\u201310280. doi: 10.1021/j100142a004.", "ArticleIdList": ["10.1021/j100142a004"]}, {"Citation": "Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., et al. Gaussian 09, Revision E01. Gaussian Inc.; Wallingford, CT, USA: 2009."}, {"Citation": "Darden T., York D., Pedersen L. Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089\u201310092. doi: 10.1063/1.464397.", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "Izaguirre J.A., Catarello D.P., Wozniak J.M., Skeel R.D. Langevin stabilization of molecular dynamics. J. Chem. Phys. 2001;114:2090\u20132098. doi: 10.1063/1.1332996.", "ArticleIdList": ["10.1063/1.1332996"]}, {"Citation": "Berendsen H.J.C., Postma J.P.M., Vangunsteren W.F., Dinola A., Haak J.R. Molecular-dynamics with coupling to an external bath. J. Chem. Phys. 1984;81:3684\u20133690. doi: 10.1063/1.448118.", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Miyamoto S., Kollman P.A. Settle\u2014An Analytical Version of the Shake and Rattle Algorithm for Rigid Water Models. J. Comput. Chem. 1992;13:952\u2013962. doi: 10.1002/jcc.540130805.", "ArticleIdList": ["10.1002/jcc.540130805"]}, {"Citation": "Fish R.H., Jaouen G. Bioorganometallic Chemistry: Structural Diversity of Organometallic Complexes with Bioligands and Molecular Recognition Studies of Several Supramolecular Hosts with Biomolecules, Alkali-Metal Ions, and Organometallic Pharmaceuticals. Organometallics. 2003;22:2166\u20132177. doi: 10.1021/om0300777.", "ArticleIdList": ["10.1021/om0300777"]}, {"Citation": "Onufriev A., Bashford D., Case D.A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins. 2004;55:383\u2013394. doi: 10.1002/prot.20033.", "ArticleIdList": ["10.1002/prot.20033", "15048829"]}, {"Citation": "Hou T., Wang J., Li Y., Wang W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J. Comput. Chem. 2011;32:866\u2013877. doi: 10.1002/jcc.21666.", "ArticleIdList": ["10.1002/jcc.21666", "PMC3043139", "20949517"]}, {"Citation": "Wang E., Sun H., Wang J., Wang Z., Liu H., Zhang J.Z.H., Hou T. End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design. Chem. Rev. 2019;119:9478\u20139508. doi: 10.1021/acs.chemrev.9b00055.", "ArticleIdList": ["10.1021/acs.chemrev.9b00055", "31244000"]}, {"Citation": "Zhao Y.H., Abraham M.H., Le J., Hersey A., Luscombe C.N., Beck G., Sherborne B., Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharm. Res. 2002;19:1446\u20131457. doi: 10.1023/A:1020444330011.", "ArticleIdList": ["10.1023/A:1020444330011", "12425461"]}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504. doi: 10.1101/gr.1239303.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Blucher A.S., McWeeney S.K., Stein L., Wu G. Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz. F1000Research. 2019;8:908. doi: 10.12688/f1000research.19592.1.", "ArticleIdList": ["10.12688/f1000research.19592.1", "PMC6644836", "31372215"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "4"}, {"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "23"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "1", "Minute": "5"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["35215266", "PMC8875976", "10.3390/ph15020153", "ph15020153"]}}], "PubmedBookArticle": []}